MAY 26, 2020 5:34 PM PDT

Alzheimer's Gene Doubles Risk of Severe COVID-19

WRITTEN BY: Annie Lennon

Researchers from the University of Exeter, England, and the University of Connecticut have found that people carrying faulty gene APOE e4e4 are more likely to have severe symptoms from COVID-19 than those with a different variant. 

The gene has previously been linked to Alzheimer's disease in Caucasian people. Having two faulty copies of the gene, common to 1 in 36 people of European descent, has been known to increase one's risk of Alzheimer's by 15 times, as well as increase one's risk of heart disease. 

For their study, the researchers analyzed data from the UK Biobank study, a collection of health and genetic data of 500,000 people. They found that while most people in the population had not been exposed to the virus, 2.36% of those with European ancestry had the APOE e4e4 gene, whereas 5.13% of those tested positive for COVID-19 had this gene variant. Meanwhile, those with the e3e3 variant of the same gene were less than half as likely to test positive for the virus. 

The researchers concluded that the APOE e4e4 gene's presence might increase one's chances of developing severe COVID-19 symptoms. These results match their previous findings showing that people with dementia are three times as likely than those without to get severe COVID-19 symptoms. 

"This is an exciting result because we might now be able to pinpoint how this faulty gene causes vulnerability to COVID-19. This could lead to new ideas for treatments. It's also important because it shows again that increasing disease risks that appear inevitable with aging might actually be due to specific biological differences, which could help us understand why some people stay active to age 100 and beyond, while others become disabled and die in their sixties." says co-author of the study, Dr. Chia-Ling Kuo. 

Professor David Melzer, lead author if the study, says, "Several studies have now shown that people with dementia are at high risk of developing severe COVID-19. This study suggests that this high risk may not simply be due to the effects of dementia, advancing age or frailty, or exposure to the virus in care homes."


 

Sources: Neuroscience News, Medscape, The Scientist, The Journals of Gerontology 

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
AUG 25, 2020
Neuroscience
Dementia Kills Almost 3 Times More than Previously Thought
AUG 25, 2020
Dementia Kills Almost 3 Times More than Previously Thought
Researchers have found that around 13.6% of deaths in the U.S. may come as the result of dementia. The figure, they say, ...
SEP 13, 2020
Neuroscience
Emotion-Color Associations are the Same Globally
SEP 13, 2020
Emotion-Color Associations are the Same Globally
Researchers from Johannes Gutenberg Universitaet Mainz in Germany have found that people, regardless of where they come ...
SEP 19, 2020
Cell & Molecular Biology
Reward and Punishment Take Similar Paths in the Mouse Brain
SEP 19, 2020
Reward and Punishment Take Similar Paths in the Mouse Brain
Scientists have determined that mice have brain cells that can help them learn to avoid bad experiences.
OCT 12, 2020
Neuroscience
Effects of Oxytocin Depend on Where it Comes From
OCT 12, 2020
Effects of Oxytocin Depend on Where it Comes From
Oxytocin has gained its reputation as the 'love hormone' for its role in regulating prosocial behaviors like emp ...
NOV 08, 2020
Neuroscience
New Way to Restore Fatty Myelin Sheaths on Nerve Cells
NOV 08, 2020
New Way to Restore Fatty Myelin Sheaths on Nerve Cells
Researchers from the F.M. Kirby Neurobiology Center in the US have discovered a new approach to restore myelin sheaths, ...
NOV 10, 2020
Neuroscience
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
NOV 10, 2020
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
Video:  Explains the challenges of delivering medicine to the brain, and possibly tools to pass the blood-brain bar ...
Loading Comments...